These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 632844)

  • 1. Biochemical studies in a patient with a Tangier syndrome.
    Yao JK; Herbert PN; Fredrickson DS; Ellefson RD; Heinen RJ; Forte T; Dyck PJ
    J Neuropathol Exp Neurol; 1978; 37(2):138-54. PubMed ID: 632844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of high density lipoproteins in lecithin:cholesterol acyltransferase activity: perspectives from Tangier disease.
    Assmann G; Schmitz G; Heckers H
    Scand J Clin Lab Invest Suppl; 1978; 150():98-102. PubMed ID: 218282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lecithin:cholesterol acyltransferase in familial HDL deficiency (Tangier disease).
    Pritchard PH; McLeod R; Frohlich J; Park MC; Kudchodkar BJ; Lacko AG
    Biochim Biophys Acta; 1988 Feb; 958(2):227-34. PubMed ID: 3122840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesteryl ester transfer activity in plasma of patients with familial high-density lipoprotein deficiency.
    Sparks DL; Frohlich J; Pritchard PH
    Clin Chem; 1988 Sep; 34(9):1812-5. PubMed ID: 3416429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different substrate specificities of plasma lecithin: cholesterol acyl transferase in fish eye disease and Tangier disease.
    Carlson LA; Holmquist L; Assmann G
    Acta Med Scand; 1987; 222(4):345-50. PubMed ID: 3425387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Net lipid transfer between lipoproteins in fish-eye disease plasma supplemented with normal high density lipoproteins.
    Holmquist L; Carlson LA
    Lipids; 1987 May; 22(5):305-11. PubMed ID: 3600207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol esterification by lecithin-cholesterol acyltransferase in A-I-free plasma.
    Cheung MC; Wang DB; Lum KD; Albers JJ
    Biochim Biophys Acta; 1988 Sep; 962(2):258-64. PubMed ID: 3139041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of the plasma very low and low density lipoproteins in Tangier disease.
    Heinen RJ; Herbert PN; Fredrickson DS
    J Clin Invest; 1978 Jan; 61(1):120-32. PubMed ID: 201668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normalization of high density lipoprotein in fish eye disease plasma by purified normal human lecithin: cholesterol acyltransferase.
    Holmquist L; Carlson LA
    Lipids; 1988 Mar; 23(3):225-9. PubMed ID: 3374277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoalpha-hyperbeta-lipoproteinemia in a patient with coronary artery disease and occlusive peripheral arterial disease.
    Toth L; Koenig W
    Atherosclerosis; 1982 Mar; 42(1):121-4. PubMed ID: 7082413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
    Wang CS; Alaupovic P; Gregg RE; Brewer HB
    Biochim Biophys Acta; 1987 Jul; 920(1):9-19. PubMed ID: 3109493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Tangier lipoproteins with cholesteryl ester-laden mouse peritoneal macrophages.
    Schmitz G; Assmann G; Brennhausen B; Schaefer HJ
    J Lipid Res; 1987 Jan; 28(1):87-99. PubMed ID: 3559403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tangier disease: a structural defect in apolipoprotein A-I (apoA-I Tangier).
    Kay LL; Ronan R; Schaefer EJ; Brewer HB
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2485-9. PubMed ID: 6806810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified lipid-protein interactions in Tangier beta lipoprotein (LDL2) demonstrated by fluorescence quenching.
    Dumon MF; Dang QQ; Salvayre R; Clerc M; Douste-Blazy L
    Chem Phys Lipids; 1988 Dec; 49(3):153-60. PubMed ID: 3240561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial lecithin:cholesterol acyltransferase deficiency: further resolution of lipoprotein particle heterogeneity in the low density interval.
    Guérin M; Dolphin PJ; Chapman MJ
    Atherosclerosis; 1993 Dec; 104(1-2):195-212. PubMed ID: 8141844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of high density lipoprotein subfractions and constituents in Tangier disease following the infusion of high density lipoproteins.
    Schaefer EJ; Anderson DW; Zech LA; Lindgren FT; Bronzert TB; Rubalcaba EA; Brewer HB
    J Lipid Res; 1981 Feb; 22(2):217-28. PubMed ID: 6787156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fish-eye disease. A new familial condition with massive corneal opacities and dyslipoproteinaemia.
    Carlson LA; Philipson B
    Lancet; 1979 Nov; 2(8149):922-4. PubMed ID: 91022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro normalization of cholesteryl ester content and particle size of fish eye disease high density lipoproteins.
    Holmquist L; Carlson LA
    Acta Med Scand; 1987; 221(3):283-9. PubMed ID: 3591466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities in plasma lipoprotein in familial partial lecithin:cholesterol acyltransferase deficiency.
    Kodama T; Akanuma Y; Okazaki M; Aburatani H; Itakura H; Takahashi K; Sakuma M; Takaku F; Hara I
    Biochim Biophys Acta; 1983 Aug; 752(3):407-15. PubMed ID: 6871236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitution in vitro of lecithin-cholesterol acyltransferase. Analysis of changes in plasma lipoproteins.
    Utermann G; Menzel HJ; Adler G; Dieker P; Weber W
    Eur J Biochem; 1980; 107(1):225-41. PubMed ID: 6772442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.